Clinical and Imaging Data-Based Model for Predicting Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in Pregnant Women With Severe Preeclampsia or Eclampsia and Analysis of Perinatal Outcomes

Table 1

General data of pregnant women in the two groups [n (%)] (general clinical data model).

Category	RPLS group	Non-RPLS group	Univariate analysis		Multivariate analysis
	(n = 33)	(n = 45)	X^2/t			Hazard ratio
Age (years)	32.64 ± 9.41	33.83 ± 9.51	0.551	0.584
Gestational week of delivery (weeks)	33.51 ± 3.12	33.69 ± 3.21	0.269	0.788
Abortion history	21	30	0.077	0.781
Primipara	16	26	0.661	0.416
Assisted reproduction	11	16	0.041	0.838
Prepregnancy BMI ≥30 kg/m^2	24	27	1.362	0.243
Multiple pregnancies	3	5	0.0844	0.771
Diabetes history	5	7	0.0023	0.961
Immune disorders	2	4	0.2144	0.643
Poor placental perfusion	30	29	2.788	0.007	0.031	3.503 (1.121–10.948)
History of eclampsia	6	9	0.04	0.84
Hypertensive emergency	23	13	3.855		0.001	7.248 (2.306–22.784)
≥2 antihypertensive drugs	22	11	4.061
History of hypertension	20	26	0.062	0.801
HELLP syndrome	3	1	0.704	0.401
Smoking or drinking history	6	10	0.19	0.662
Headache	24	13	4.197		0.009	4.464 (1.460–13.654)
Blurred vision	20	18	3.235	0.072
Convulsions	8	5	1.541	0.127
Mental or consciousness disorders	14	11	2.826	0.092
Severe preeclampsia/eclampsia	16	23	0.0525	0.8187